Cooley advised the underwriters on Centessa Pharmaceuticals’ $380 million initial public offering of 18,975,000 American depositary shares ADSs, which includes the full exercise of the underwriters’ option to purchase additional shares. Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Jefferies LLC and Evercore Group LLC, acted as joint book-running managers for the offering. Centessa Pharmaceuticals, whose securities now trade on the Nasdaq Global Select Market under the symbol “CNTA,” is a clinical-stage company employing its asset-centric business model to discover, develop and deliver impactful medicines to patients. Partners Div Gupta, Claire Keast-Butler, Josh Kaufman and Geoffrey Starr led the Cooley team.